Effectiveness and safety of long duration vs short duration diode laser transscleral cyclophotocoagulation
Clinical Ophthalmology Jan 28, 2020
Chan JC, et al. - In this retrospective series of 23 consecutive patients (23 eyes), age 49– 90 (71.3 ± 2.7), with glaucoma, researchers compared the safety and effectiveness of diode laser transscleral cyclophotocoagulation utilizing either the long duration or short-duration protocol. Participants in the study were patients who had continuous-wave diode laser transscleral cyclophotocoagulation from August 2016 to July 2018 at a tertiary hospital in Hong Kong. According to findings, both types of cyclophotocoagulation were similarly effective in reducing intraocular pressure by 6 months, but the short duration protocol was able to achieve a higher and earlier reduction at 3 months using higher laser power. However, the protocol for a long duration, which uses less laser power, seems better to reduce the need for medication by 6 months.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries